Entrada Therapeutics, Inc.
Current- Director 2017 to present
Skip to record
Executive record
Alpha ID: alpha:person:natarajan-sethuramanVersion: public-0:d751713988987e9331980363e24189ceAs of: 2026-10-05
Not yet claimed7 published Claims3 sources
- Director
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
- Professional RoleDirector at Entrada Therapeutics, Inc.www.sec.gov
- Board membershipServes on the board of Entrada Therapeutics, Inc.www.sec.gov
- Executive titleExecutive title: President of Research and DevelopmentTRDA DEF 14A executive officers
- AI and ML experienceAI and ML experience: not identified in the cited filingTRDA DEF 14A executive officers
Biography
Natarajan Sethuraman, Ph.D., serves as President of Research and Development at Entrada Therapeutics, Inc.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Boards
Claims
Executive career
- 2026 to end not publishedExecutive title: President of Research and Development · Organization not publishedTRDA DEF 14A executive officers
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
TRDA DEF 14A executive officers
sec filing · Source published: Apr 24, 2026 · Retrieved: May 5, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
- Executive company: Executive at Entrada Therapeutics, Inc. · Claim reviewed: May 5, 2026
- Executive title: Executive title: President of Research and Development · Claim reviewed: May 5, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026
Open source
sec proxy · Source published: Apr 24, 2026 · Retrieved: Sep 2, 2026
Supports 1 claim
- Professional Role: Director at Entrada Therapeutics, Inc. · Claim reviewed: May 5, 2026
Open source
public source · Source published: Date unavailable · Retrieved: Date unavailable
Supports 1 claim
- Board membership: Serves on the board of Entrada Therapeutics, Inc. · Claim reviewed: May 5, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-05
- Biography
- published
- Board service
- published
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope